# SPRUCE BIOSCIENCES, INC. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:1c839749-b30c-41d0-959b-bd2a64f39716 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/spruce-biosciences-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 23 | | Claims under review | 1 | | Evidence records | 7 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-10-17T04:46:47.349247+00:00 | | Last reviewed | 2026-10-17T04:46:47.349247+00:00 | ## Identity - Legal name: SPRUCE BIOSCIENCES, INC. - Display name: SPRUCE BIOSCIENCES, INC. ## Alpha Governance Record | Field | Value | | --- | --- | | Governance Record schema | alpha-governance-record-v2 | | Ontology | alpha-governance-ontology-v1 | | Record version | public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce | | As of | 2026-10-17T07:55:17.988376+00:00 | | Completeness | 0.409 | | Record Quality | 0.842 | | Directors | 7 | | Committees | 5 | | Governance events | 16 | | Entity class | public_company | ## Section coverage | Section | State | | --- | --- | | identity | PUBLISHED | | corporate_structure | NOT_REVIEWED | | board | PUBLISHED | | committees | PUBLISHED | | leadership | PUBLISHED | | ownership | NOT_REVIEWED | | financials | NOT_REVIEWED | | capital_structure | PUBLISHED | | compensation | NOT_REVIEWED | | governance | NOT_REVIEWED | | shareholder_governance | NOT_REVIEWED | | audit | NOT_REVIEWED | | legal | NOT_REVIEWED | | risk | NOT_REVIEWED | | cyber | NOT_REVIEWED | | ai_governance | NOT_REVIEWED | | agent_governance | RESTRICTED | | markets_external | NOT_REVIEWED | | events | PUBLISHED | | relationships | PUBLISHED | | assessments | PUBLISHED | | evidence | PUBLISHED | ## Board - Camilla V. Simpson, M.Sc.: Director. Status: current. Independent: true. Since: 2017-01-01. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:5 - Daniel Spiegelman: Director. Status: current. Independent: true. Since: 2020-01-01. Committees: Audit (chair); Audit · Chair; Nominating and Governance (member); Nominating and Governance (member). claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:6 - Javier Szwarcberg, M.D., MPH: Director. Status: current. Independent: false. Since: 2022-01-01. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:7 - Keli Walbert: Director. Status: current. Independent: true. Since: 2025-01-01. Committees: Compensation (member). claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:8 - Kirk Ways, M.D., Ph.D.: Director. Status: current. Independent: false. Since: 2021-01-01. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:9 - Michael Grey: Director. Status: current. Independent: false. Since: 2017-01-01. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:10 - Percival Barretto-Ko: Director. Status: current. Independent: true. Since: 2023-01-01. Committees: Audit (member); Audit; Compensation (member); Compensation (member). claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:11 ## Committees - Audit (audit). Chair: Daniel Spiegelman. Members: Daniel Spiegelman (chair, current); Percival Barretto-Ko (member, current). committee_id=alpha:committee:spruce-biosciences-inc:audit - Audit · Chair; Nominating and Governance (audit). Chair: NOT_PUBLISHED. Members: Daniel Spiegelman (member, current). committee_id=alpha:committee:spruce-biosciences-inc:audit-chair-nominating-and-governance - Audit; Compensation (audit). Chair: NOT_PUBLISHED. Members: Percival Barretto-Ko (member, current). committee_id=alpha:committee:spruce-biosciences-inc:audit-compensation - Compensation (compensation). Chair: NOT_PUBLISHED. Members: Keli Walbert (member, current); Percival Barretto-Ko (member, current). committee_id=alpha:committee:spruce-biosciences-inc:compensation - Nominating and Governance (nominating_governance). Chair: NOT_PUBLISHED. Members: Daniel Spiegelman (member, current). committee_id=alpha:committee:spruce-biosciences-inc:nominating-and-governance ## Executive leadership - Corwin Dale Hooks: Chief Commercial Officer. Status: current. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:12 - Javier Szwarcberg, M.D., MPH: Chief Executive Officer and Director [CEO]. Status: current. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:13 - Kirk Ways, M.D., Ph.D.: Interim Chief Medical Officer. Status: current. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:14 - Samir Gharib: President and Chief Financial Officer [CFO]. Status: current. claim_id=alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:15 ## Governance events - EXECUTIVE_APPOINTED: Corwin Dale Hooks executive of SPRUCE BIOSCIENCES, INC., effective 2026-04-09. Effective: 2026-04-09. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1sv2ysy1bef36 - CEO_CHANGED: Javier Szwarcberg, M.D., MPH executive of SPRUCE BIOSCIENCES, INC., effective 2026-04-09. Effective: 2026-04-09. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1nheqte1c17sam - EXECUTIVE_APPOINTED: Kirk Ways, M.D., Ph.D. executive of SPRUCE BIOSCIENCES, INC., effective 2026-04-09. Effective: 2026-04-09. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:shpaewt07218 - CFO_CHANGED: Samir Gharib executive of SPRUCE BIOSCIENCES, INC., effective 2026-04-09. Effective: 2026-04-09. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:15ytq8y11behkk - DIRECTOR_APPOINTED: Keli Walbert seat on SPRUCE BIOSCIENCES, INC., effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:16wul3e1xrj06o - COMMITTEE_MEMBER_ADDED: Keli Walbert member of Compensation, effective 2025-01-01. Effective: 2025-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:f2cee21wum7c - DIRECTOR_APPOINTED: Percival Barretto-Ko seat on SPRUCE BIOSCIENCES, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:3p8j141bvl27i - COMMITTEE_CREATED: Audit; Compensation committee of SPRUCE BIOSCIENCES, INC., effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1xayucacqpm2y - COMMITTEE_MEMBER_ADDED: Percival Barretto-Ko member of Audit; Compensation, effective 2023-01-01. Effective: 2023-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1dvmwbkxri1e2 - DIRECTOR_APPOINTED: Javier Szwarcberg, M.D., MPH seat on SPRUCE BIOSCIENCES, INC., effective 2022-01-01. Effective: 2022-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1p3izys1yqdqzg - DIRECTOR_APPOINTED: Kirk Ways, M.D., Ph.D. seat on SPRUCE BIOSCIENCES, INC., effective 2021-01-01. Effective: 2021-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:1n1sgrp1figcuh - DIRECTOR_APPOINTED: Daniel Spiegelman seat on SPRUCE BIOSCIENCES, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:10xpeud1q8p9fv - COMMITTEE_CREATED: Audit · Chair; Nominating and Governance committee of SPRUCE BIOSCIENCES, INC., effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:fzf7s112ran0j - COMMITTEE_MEMBER_ADDED: Daniel Spiegelman member of Audit · Chair; Nominating and Governance, effective 2020-01-01. Effective: 2020-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:9w2wsu3trvas - DIRECTOR_APPOINTED: Camilla V. Simpson, M.Sc. seat on SPRUCE BIOSCIENCES, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:mmm2wq1jce89o - DIRECTOR_APPOINTED: Michael Grey seat on SPRUCE BIOSCIENCES, INC., effective 2017-01-01. Effective: 2017-01-01. Detected: 2026-10-17T04:46:47.349247+00:00. event_id=alpha:event:transition:9bmj9a11vki7c ## Scoped resources - `alpha://company/spruce-biosciences-inc` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record - `alpha://company/spruce-biosciences-inc/identity` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=identity - `alpha://company/spruce-biosciences-inc/corporate-structure` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=corporate-structure - `alpha://company/spruce-biosciences-inc/board` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=board - `alpha://company/spruce-biosciences-inc/committees` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=committees - `alpha://company/spruce-biosciences-inc/leadership` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=leadership - `alpha://company/spruce-biosciences-inc/ownership` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=ownership - `alpha://company/spruce-biosciences-inc/financials` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=financials - `alpha://company/spruce-biosciences-inc/capital-structure` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=capital-structure - `alpha://company/spruce-biosciences-inc/compensation` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=compensation - `alpha://company/spruce-biosciences-inc/governance` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=governance - `alpha://company/spruce-biosciences-inc/shareholder-governance` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=shareholder-governance - `alpha://company/spruce-biosciences-inc/audit` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=audit - `alpha://company/spruce-biosciences-inc/legal` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=legal - `alpha://company/spruce-biosciences-inc/risk` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=risk - `alpha://company/spruce-biosciences-inc/cyber` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=cyber - `alpha://company/spruce-biosciences-inc/ai-governance` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=ai-governance - `alpha://company/spruce-biosciences-inc/agents` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=agents - `alpha://company/spruce-biosciences-inc/ecosystem` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=ecosystem - `alpha://company/spruce-biosciences-inc/events` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=events - `alpha://company/spruce-biosciences-inc/relationships` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=relationships - `alpha://company/spruce-biosciences-inc/assessments` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=assessments - `alpha://company/spruce-biosciences-inc/evidence` (contract): https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record§ion=evidence ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - Claim alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:17: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"chair","person":{"alpha_id":"alpha:person:daniel-spiegelman","name":"Daniel Spiegelman"},"source_id":"board_seats"}` - Claim alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:18: `{"kind":"committee_appointment","original_name":"Audit","category":"audit","role":"member","person":{"alpha_id":"alpha:person:percival-barretto-ko","name":"Percival Barretto-Ko"},"source_id":"board_seats"}` - Claim alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:20: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:keli-walbert","name":"Keli Walbert"},"source_id":"board_seats"}` - Claim alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:21: `{"kind":"committee_appointment","original_name":"Compensation","category":"compensation","role":"member","person":{"alpha_id":"alpha:person:percival-barretto-ko","name":"Percival Barretto-Ko"},"source_id":"board_seats"}` - Claim alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:23: `{"kind":"committee_appointment","original_name":"Nominating and Governance","category":"nominating_governance","role":"member","person":{"alpha_id":"alpha:person:daniel-spiegelman","name":"Daniel Spiegelman"},"source_id":"board_seats"}` ## Leadership - Camilla V. Simpson, M.Sc.: Director. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:5. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Daniel Spiegelman: Director, Audit · Chair; Nominating and Governance. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Javier Szwarcberg, M.D., MPH: Director. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:7. Valid from: 2022-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Keli Walbert: Director, Compensation. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:8. Valid from: 2025-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Kirk Ways, M.D., Ph.D.: Director. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:9. Valid from: 2021-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Michael Grey: Director. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:10. Valid from: 2017-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Percival Barretto-Ko: Director, Audit; Compensation. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:11. Valid from: 2023-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5. - Corwin Dale Hooks: Chief Commercial Officer. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:12. Valid from: 2026-04-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:f28d3722cff3f14551dd0b8303ada655110506808094940252f510d20e7bc184. - Javier Szwarcberg, M.D., MPH: Chief Executive Officer and Director. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:13. Valid from: 2026-04-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:78f679df1beffc55831d035298ccd996c2f35003b424ebf1758e552044e9db14. - Kirk Ways, M.D., Ph.D.: Interim Chief Medical Officer. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:14. Valid from: 2026-04-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:9fa9e7ca9c7b910b753326234ae9811fdf64bb04c99aa1c7de26e495c90714a3. - Samir Gharib: President and Chief Financial Officer. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:leadership_role:15. Valid from: 2026-04-09. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:document:517c7c715951f89d315eb7f9b298f9dbe8ec2a700cc69520c2aa7b95c58ffa17. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - Audit: Chair Daniel Spiegelman; Members Daniel Spiegelman (Chair); Percival Barretto-Ko. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_record:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Compensation: Chair not stated; Members Keli Walbert; Percival Barretto-Ko. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_record:19. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Nominating and Governance: Chair not stated; Members Daniel Spiegelman. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_record:22. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - SPRUCE BIOSCIENCES, INC.. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:74edb0c0d724864a42141f072063e87467907f5a55726ead6821923c5b931779. ## Entity Status - Public listing published. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:74edb0c0d724864a42141f072063e87467907f5a55726ead6821923c5b931779. ## Published Fact - US. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:74edb0c0d724864a42141f072063e87467907f5a55726ead6821923c5b931779. ## Committee Appointment - Daniel Spiegelman: chair, Audit. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:17. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Percival Barretto-Ko: member, Audit. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Keli Walbert: member, Compensation. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Percival Barretto-Ko: member, Compensation. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:21. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. - Daniel Spiegelman: member, Nominating and Governance. Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:committee_appointment:23. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1. ## Security Listing - SPRB (NASDAQ). Claim: alpha:claim:company:1c839749-b30c-41d0-959b-bd2a64f39716:security_listing:24. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:projection-evidence:74edb0c0d724864a42141f072063e87467907f5a55726ead6821923c5b931779. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:projection-evidence:74edb0c0d724864a42141f072063e87467907f5a55726ead6821923c5b931779: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/spruce-biosciences-inc). - alpha:projection-evidence:document:29a7a16cc95581a8c4bc7e9654c85da618f8cf194b348d08273b9e37cc27bcf5: [SPRUCE BIOSCIENCES, INC. DEF 14A 2026-04-09](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). - alpha:projection-evidence:document:f28d3722cff3f14551dd0b8303ada655110506808094940252f510d20e7bc184: [SPRB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). - alpha:projection-evidence:document:78f679df1beffc55831d035298ccd996c2f35003b424ebf1758e552044e9db14: [SPRB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). - alpha:projection-evidence:document:9fa9e7ca9c7b910b753326234ae9811fdf64bb04c99aa1c7de26e495c90714a3: [SPRB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). - alpha:projection-evidence:document:517c7c715951f89d315eb7f9b298f9dbe8ec2a700cc69520c2aa7b95c58ffa17: [SPRB DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). - alpha:projection-evidence:820a4e20e0834d6d3290f4b692167c8481b30733b1e64ae76b697390fe8cb4b1: [Audit](https://www.sec.gov/Archives/edgar/data/1683553/000119312526149821/sprb-20260409.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/spruce-biosciences-inc) - [Public Markdown](https://registry.alpha.ac/companies/spruce-biosciences-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/spruce-biosciences-inc?format=jsonld) - MCP resource: `alpha://companies/spruce-biosciences-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Only explicitly published, rights-cleared records. Missing records do not establish absence, safety, or complete coverage. ## Critical-risk oversight Snapshot as of 2026-10-17T07:55:17.775521+00:00; recorded 2026-10-17T07:55:17.775521+00:00. Every published assignment for this snapshot is listed. Only explicitly reviewed, rights-cleared assignments in effect on the as-of date, in the company's own wording. An assignment shows where oversight is placed, not whether it is effective. Missing records do not establish absence.